User:Z3415141: Difference between revisions
No edit summary |
|||
Line 8: | Line 8: | ||
Some women for personal reasons prefer to take subcutaneous progesterone for luteal phase support when undergoing in vitro fertilization (IVF) in an attempt to avoid some of the side effects of vaginal progesterone. In attempting to work out whether the luteal phase of IVF better supports the ongoing pregnancy rate with the use of either the new aqueous preparation of subcutaneous progesterone or vaginal progesterone 800 random women aged between 18-42 years undergoing IVF received an embryo transfer where 3 oocytes were randomly placed in either a preparation progesterone administered subcutaneously or vaginal progesterone. If a viable pregnancy was to occur, then progesterone treatment continued for up to 12 weeks of the gestation process. | Some women for personal reasons prefer to take subcutaneous progesterone for luteal phase support when undergoing in vitro fertilization (IVF) in an attempt to avoid some of the side effects of vaginal progesterone. In attempting to work out whether the luteal phase of IVF better supports the ongoing pregnancy rate with the use of either the new aqueous preparation of subcutaneous progesterone or vaginal progesterone 800 random women aged between 18-42 years undergoing IVF received an embryo transfer where 3 oocytes were randomly placed in either a preparation progesterone administered subcutaneously or vaginal progesterone. If a viable pregnancy was to occur, then progesterone treatment continued for up to 12 weeks of the gestation process. | ||
It was found that the pregnancy rate for vaginal progesterone (44.4%) in comparison to subcutaneous progesterone (41.6%) was consistently higher. While luteal phase support has clearly shown to improve pregnancy rates in women in the past this research shows that those women whom chose to go with the subcutaneous progesterone preparations are less likely to have a successful pregnancy than those who go with the traditional vaginal progesterone in supporting the luteal phase of IVF. It is important to note though due to the relatively small sample and dosage sizes of this study and the fairly small difference between the two groups this study is not totally conclusive. |
Revision as of 21:06, 12 August 2014
Welcome to the 2014 Embryology Course!
- Links: Timetable | How to work online | One page Wiki Reference Card | Moodle
- Each week the individual assessment questions will be displayed in the practical class pages and also added here.
- Copy the assessment items to your own page and provide your answer.
- Note - Some guest assessments may require completion of a worksheet that will be handed in in class with your student name and ID.
Individual Lab Assessment |
---|
|
Lab 12 - Stem Cell Presentation Assessment | More Info | |
---|---|---|
Group | Comment | Mark (10) |
1/8 |
|
7 |
2 |
|
7.5 |
3 |
|
7.5 |
4 |
|
8.5 |
5 |
|
8.5 |
6 |
|
8.5 |
7 |
|
7.5 |
--Z3415141 (talk) 12:48, 6 August 2014 (EST)
Online Assessment 1
<pubmed>25100106</pubmed>
Some women for personal reasons prefer to take subcutaneous progesterone for luteal phase support when undergoing in vitro fertilization (IVF) in an attempt to avoid some of the side effects of vaginal progesterone. In attempting to work out whether the luteal phase of IVF better supports the ongoing pregnancy rate with the use of either the new aqueous preparation of subcutaneous progesterone or vaginal progesterone 800 random women aged between 18-42 years undergoing IVF received an embryo transfer where 3 oocytes were randomly placed in either a preparation progesterone administered subcutaneously or vaginal progesterone. If a viable pregnancy was to occur, then progesterone treatment continued for up to 12 weeks of the gestation process.
It was found that the pregnancy rate for vaginal progesterone (44.4%) in comparison to subcutaneous progesterone (41.6%) was consistently higher. While luteal phase support has clearly shown to improve pregnancy rates in women in the past this research shows that those women whom chose to go with the subcutaneous progesterone preparations are less likely to have a successful pregnancy than those who go with the traditional vaginal progesterone in supporting the luteal phase of IVF. It is important to note though due to the relatively small sample and dosage sizes of this study and the fairly small difference between the two groups this study is not totally conclusive.